Epigenetic profiling of CDH1 and NISCH promoter methylation in plasma-derived cell-free DNA for potential diagnosis of lung cancer
CDH1 and NISCH promoter methylation in blood-derived cfDNA highlights the innovation of non-invasive approach alternative to tissue biopsy, with potential to complement existing screening modalities such as low-dose CT by improving molecular level detection and reducing false-positive rates.